Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)

被引：6

作者：

Hong, D. S. ^{[1
]}

Bang, Y-J. ^{[2
]}

Barlesi, F. ^{[3
]}

Durm, G. A. ^{[4
]}

Falchook, G. S. ^{[5
]}

Govindan, R. ^{[6
]}

Dy, G. K. ^{[7
]}

Park, K. ^{[8
]}

Strickler, J. H. ^{[9
]}

Burns, T. F. ^{[10
]}

Kim, J. ^{[11
]}

Ang, A. ^{[12
]}

Lipford, J. R. ^{[13
]}

Ngarmchamnanrith, G.

Anderson, A. ^{[12
]}

Li, B. T. ^{[14
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Phase & Clin Trials Program, Dept Invest Canc Therapeut, Houston, TX 77030 USA

[2] Seoul Natl Univ, Coll Med, Dept Internal Med Med Oncol, Seoul, South Korea

[3] Aix Marseille Univ, CNRS, INSERM, CRCM,AP HP, Gustave Roussy Canc Campus, Villejuif, France

[4] Indiana Univ, Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN USA

[5] HealthONE, Sarah Cannon Res Inst, Dept Med Oncol, Denver, CO USA

[6] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA

[7] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

[8] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[9] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA

[10] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Dept Med,Div Hematol Oncol, Pittsburgh, PA USA

[11] Amgen Inc, Biostat, Thousand Oaks, CA 91320 USA

[12] Amgen Inc, Oncol Res, Thousand Oaks, CA 91320 USA

[13] Amgen Inc, Clin Dev, Thousand Oaks, CA 91320 USA

[14] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.1571

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1257O

引用

页码：S812 / S812

页数：1

共 50 条

[31] Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer
Higgins, Jordyn P.
Carlisle, Jennifer W.
Moniri, Nader H.
Gupta, Shruti
Oduah, Eziafa I.
Leal, Ticiana
FUTURE ONCOLOGY, 2025, 21 (01) : 63 - 71
[32] ERLOTINIB AND BEXAROTENE FOR PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Dragnev, K. H.
Seltzer, M.
Rigas, J. R.
DiSalvo, W. M.
Simeone, S.
Johnstone, D.
Nugent, W.
Waxman, S.
Dmitrovsky, E.
ANNALS OF ONCOLOGY, 2008, 19 : 102 - 102
[33] Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010
Acres, B.
Quoix, E.
Ramlau, R.
Lacoste, G.
Bastien, B. Marie
Tavernaro, A.
Bettinger, S.
Bizouarne, N.
Limacher, J. M.
Bonnefoy, J. Y.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[34] Results of clinical study of induction chemoimmunotherapy (iCIT) in patients (pts) with non-small cell lung cancer (NSCLC)
Lazutin, Yuriy N.
Kit, Oleg Ivanovich
Turkin, Igor N.
Kharitonova, Anna Pavlovna
Vladimirova, Liubov Yu
Sergostyants, Gennadiy Z.
Pyltsin, Sergey P.
Chubaryan, Anna V.
Ayrapetova, Tamara G.
Anistratov, Pavel A.
Leyman, Igor A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[35] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Papachristos, A.
Masinde, S.
Davis, J. D.
Gullo, G.
Rietschel, P.
Paccaly, A.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
[36] Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP).
Ellis, Peter G.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[37] Actionable biomarkers in a non-small cell lung cancer (NSCLC) clinical pathway (CP).
Ellis, Peter G.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
[38] VISUAL DISTURBANCES IN PATIENTS (PTS) WITH ANAPLASTIC LYMPHOMA KINASE (ALK)-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH CRIZOTINIB
Besse, B.
Salgia, R.
Solomon, B.
Shaw, A.
Kim, D.
Schachar, R.
Wilner, K.
Reisman, A.
Bartlett, C. H.
Iyer, S.
ANNALS OF ONCOLOGY, 2012, 23 : 416 - 416
[39] Lorlatinib in patients (Pts) with previously treated ALK+ advanced non-small cell lung cancer (NSCLC): Updated efficacy and safety.
Besse, Benjamin
Solomon, Benjamin J.
Felip, Enriqueta
Bauer, Todd Michael
Ou, Sai-Hong Ignatius
Soo, Ross A.
Camidge, D. Ross
Chiari, Rita
Gadgeel, Shirish M.
Riely, Gregory J.
Tan, Eng Huat
Hayashi, Hidetoshi
Mazieres, Julien
Thurm, Holger C.
Martini, Jean-Francois
Abbattista, Antonello
Peltz, Gerson
Clancy, Jill S.
Shaw, Alice Tsang
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[40] CLINICAL SIGNIFICANCE OF PRETREATMENT PLASMA BIOMARKERS IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
Han, Xiaohong
Wang, Shuai
Hu, Xingsheng
Wang, Xiaoyuan
Zhao, Ling Di
Tang, Le
Feng, Yun
Wu, Di
Sun, Yan
Shi, Yuankai
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S807 - S807

← 1 2 3 4 5 →